Federal Cannabis Lobby Spending Set to Outpace 2018 Totals


2019-07-27 01:40:11 Ganjapreneur


Cannabis industry lobbying spending in Washington, D.C. is on pace to break the record levels set last year, according to a Marketwatch report. In 2018, the industry spent $2.7 million on lobbying efforts at the Capitol, while so far this year, cannabusinesses have already spent $1.6 million. The total through June already outpaced all of the lobbying spending by the cannabis industry in 2017, which tripled from 2016 figures outlined in the report. Mark De Souza, CEO of Illinois-based Revolution Enterprises, told Marketwatch that the lobbying efforts are not only to convince lawmakers to pass cannabis law reform bills in Congress, but that the industry is competing against other industries it might have conflicts with – such as alcohol, tobacco, and pharma. “So I could see the justification for the industry as it’s growing to start to want to have a voice and seat at the table. Anytime an industry comes in and is disruptive on any level, there’s always going to be some friction.” – De Souza, to Marketwatch Curaleaf Holdings. Inc., and Surterra Holdings Inc. both led the industry’s lobbying spending in quarter two, with $200,000 and $120,000, respectively, the report says. Earlier this month, Curaleaf announced it had agreed to acquire GR Companies Inc. – or Grassroots – for $875 million in cash and stock. Once approved, the combined company is set to become the largest cannabis firm in the world. The Cannabis Trade Federation spent $190,000, and CEO Ned Levine told Marketwatch that the STATES Act – which would prevent the federal government from interfering with state-approved cannabis policy – is the organization’s “top priority.” Levine notes that the Sen. Elizabeth Warren-sponsored bill “now has 60 co-sponsors in the House, including 15 members of the Judiciary Committee.” “We are pleased to sere significant momentum building behind the push for cannabis policy reform at the federal level,” he said in a statement to Marketwatch. De Souza suggests that another industry normalization bill – the SAFE Banking Act – could get a vote next year. He suggested that the bill is buoyed by the fact it was granted a hearing by the Senate Committee on Banking, Housing and Urban Affairs. If the record spending continues, the industry is expected to devote more than $3 million on lobbying by the end of the year. Get daily news insights in your inbox. Subscribe End Authored By: TG is a journalist by trade and has covered cannabis industry news for Ganjapreneur.com since 2014. He teaches media studies at an upstate New York university and is also the host of the Ganjapreneur Podcast.
根据 MarketWatch 的一份报告,位于华盛顿特区的大麻产业游说支出有望打破去年创下的纪录。2018年,该行业在国会大厦的游说活动上花费了270万美元,而今年迄今为止,滥用枪支已经花费了160万美元。 截至今年6月,大麻产业的游说支出总额已超过2017年大麻产业的全部支出,比报告中概述的2016年增长了两倍。 总部位于伊利诺伊州的革命企业( Revolution Enterprises )首席执行官马克•德苏扎( Mark De Souza )向市场观察( Marketwatch )表示,游说努力不仅是为了说服议员们在国会通过大麻法律改革法案,而且该行业正与其它可能与之冲突的行业展开竞争,比如酒精、烟草和制药。 “因此,我可以看到,随着该行业日益增长,开始希望在谈判桌上拥有发言权和席位,这一行业有其合理性。每当一个行业进入并且在任何层面都具有破坏性时,总是会有一些摩擦。”– De Souza , to Marketwatch Curaleaf Holdings 。报告称,公司和 Surterra Holdings Inc .均在第二季度引领行业游说支出,分别为20万美元和12万美元。 本月早些时候, Curaleaf 宣布同意以8.75亿美元现金和股票的价格收购 GR 公司。一旦获得批准,合并后的公司将成为世界上最大的大麻公司。 坎纳比斯贸易联盟花费了19万美元,首席执行官内德·莱文告诉市场观察,《国家法案》将阻止联邦政府干预国家批准的大麻政策,是该组织的“首要任务”。莱文指出,参议员。伊丽莎白•沃伦( Elizabeth Warren )发起的法案“目前在众议院有60名共同提案国,其中包括15名司法委员会成员”。 “我们很高兴看到,在联邦层面推动大麻政策改革的努力取得了重大进展,”他在向 Marketwatch 发表的一份声明中表示。 De Souza 表示,另一项行业正常化法案——国家外汇管理局《银行业法案》( SAFE Banking Act )——可能在明年获得表决。他建议,该法案得到参议院银行、住房和城市事务委员会的听证支持。 如果这一创纪录的支出持续下去,预计到今年年底,该行业将投入300多万美元用于游说。 在你的收件箱中获取每日新闻信息。认购 结束 授权人: TG 是一名贸易记者,为 Ganjaprender 报道了大麻行业的新闻。自2014年以来。他在纽约北部的一所大学教授媒体研究,也是甘贾丁·庞德斯特的主持人。